The continuum of ovarian response leading to BIRTH, a real world study of ART in Spain

BACKGROUND: The first biosimilar of recombinant follicle stimulating hormone (rFSH) launched in Europe was Bemfola® in 2014 following a clinical development programme demonstrating efficacy and safety to the satisfaction of the European Medicines Agency. Since then the increasing use of biosimilar r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrando, Marcos, Coroleu, Buenaventura, Rodríguez-Tabernero, Luis, Barrenetxea, Gorka, Guix, Cristina, Sánchez, Fernando, Jenkins, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388222/
https://www.ncbi.nlm.nih.gov/pubmed/32742711
http://dx.doi.org/10.1186/s40738-020-00081-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388222/
https://www.ncbi.nlm.nih.gov/pubmed/32742711
http://dx.doi.org/10.1186/s40738-020-00081-4

Ejemplares similares